Liver transplantation for variceal hemorrhage

R. P. Wood, Byers Wendell Shaw Jr, L. F. Rikkers

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Liver transplantation is an important therapeutic option for selected patients who bleed from varices. Although not appropriate for individuals with normal hepatocellular function and variceal hemorrhage (e.g., schistosomiasis and portal vein thrombosis), survival rates after transplantation are superior to all other therapies for bleeding varices in patients with advanced liver disease (Child's class C). In patients with variceal hemorrhage and good hepatic functional reserve (Child's classes A and B), sclerotherapy is the preferred initial treatment, with shunts or transplantation being reversed for sclerotherapy failures. Potential transplant candidates who have received other treatments for variceal bleeding (sclerotherapy or surgery) should be closely monitored so that they can undergo transplantation before they become prohibitive operative risks.

Original languageEnglish (US)
JournalSurgical Clinics of North America
Volume70
Issue number2
DOIs
StatePublished - Jan 1 1990

Fingerprint

Liver Transplantation
Sclerotherapy
Hemorrhage
Transplantation
Varicose Veins
Schistosomiasis
Therapeutics
Portal Vein
Liver Diseases
Thrombosis
Survival Rate
Transplants
Liver

ASJC Scopus subject areas

  • Surgery

Cite this

Liver transplantation for variceal hemorrhage. / Wood, R. P.; Shaw Jr, Byers Wendell; Rikkers, L. F.

In: Surgical Clinics of North America, Vol. 70, No. 2, 01.01.1990.

Research output: Contribution to journalArticle

Wood, R. P. ; Shaw Jr, Byers Wendell ; Rikkers, L. F. / Liver transplantation for variceal hemorrhage. In: Surgical Clinics of North America. 1990 ; Vol. 70, No. 2.
@article{87cd02d925a246af8360f53d363fb11d,
title = "Liver transplantation for variceal hemorrhage",
abstract = "Liver transplantation is an important therapeutic option for selected patients who bleed from varices. Although not appropriate for individuals with normal hepatocellular function and variceal hemorrhage (e.g., schistosomiasis and portal vein thrombosis), survival rates after transplantation are superior to all other therapies for bleeding varices in patients with advanced liver disease (Child's class C). In patients with variceal hemorrhage and good hepatic functional reserve (Child's classes A and B), sclerotherapy is the preferred initial treatment, with shunts or transplantation being reversed for sclerotherapy failures. Potential transplant candidates who have received other treatments for variceal bleeding (sclerotherapy or surgery) should be closely monitored so that they can undergo transplantation before they become prohibitive operative risks.",
author = "Wood, {R. P.} and {Shaw Jr}, {Byers Wendell} and Rikkers, {L. F.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/S0039-6109(16)45091-7",
language = "English (US)",
volume = "70",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Liver transplantation for variceal hemorrhage

AU - Wood, R. P.

AU - Shaw Jr, Byers Wendell

AU - Rikkers, L. F.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Liver transplantation is an important therapeutic option for selected patients who bleed from varices. Although not appropriate for individuals with normal hepatocellular function and variceal hemorrhage (e.g., schistosomiasis and portal vein thrombosis), survival rates after transplantation are superior to all other therapies for bleeding varices in patients with advanced liver disease (Child's class C). In patients with variceal hemorrhage and good hepatic functional reserve (Child's classes A and B), sclerotherapy is the preferred initial treatment, with shunts or transplantation being reversed for sclerotherapy failures. Potential transplant candidates who have received other treatments for variceal bleeding (sclerotherapy or surgery) should be closely monitored so that they can undergo transplantation before they become prohibitive operative risks.

AB - Liver transplantation is an important therapeutic option for selected patients who bleed from varices. Although not appropriate for individuals with normal hepatocellular function and variceal hemorrhage (e.g., schistosomiasis and portal vein thrombosis), survival rates after transplantation are superior to all other therapies for bleeding varices in patients with advanced liver disease (Child's class C). In patients with variceal hemorrhage and good hepatic functional reserve (Child's classes A and B), sclerotherapy is the preferred initial treatment, with shunts or transplantation being reversed for sclerotherapy failures. Potential transplant candidates who have received other treatments for variceal bleeding (sclerotherapy or surgery) should be closely monitored so that they can undergo transplantation before they become prohibitive operative risks.

UR - http://www.scopus.com/inward/record.url?scp=0025213008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025213008&partnerID=8YFLogxK

U2 - 10.1016/S0039-6109(16)45091-7

DO - 10.1016/S0039-6109(16)45091-7

M3 - Article

VL - 70

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 2

ER -